Stanley R. Hamilton

103.5k citations

400 papers · 67.0k indexed · 34 hit papers · h-index 113

Oncology top 0.01%
Pathology and Forensic Medicine top 0.01%
Molecular Biology top 0.05%
Cancer Research top 0.01%
Surgery top 0.02%

Co-authors: Bert Vogelstein Eric R. Fearon Scott E. Kern Johannes L. Bos Kenneth W. Kinzler Francis M. Giardiello Stephen N. Thibodeau Alida M.M. Smits
Topics: Genetic factors in colorectal cancer (157 papers)Colorectal Cancer Treatments and Studies (103 papers)Colorectal Cancer Screening and Detection (64 papers)
Cited by: Pathology and Forensic Medicine Oncology Cancer Research
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Netherlands Canada

In The Last Decade

Stanley R. Hamilton

392 papers receiving 65.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic Alterations during Colorectal-Tumor Development

1988 5.2k citations Stanley R. Hamilton et al. profile →
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

1998 3.3k citations Stephen N. Thibodeau, Stanley R. Hamilton et al. PubMed profile →
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas

1989 1.7k citations Stanley R. Hamilton et al. profile →
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

2003 1.6k citations Christine Ribic, Daniel J. Sargent et al. profile →
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

1998 1.5k citations Jean‐Pierre J. Issa, Stanley R. Hamilton et al. profile →
Prevalence of ras gene mutations in human colorectal cancers

1987 1.5k citations Stanley R. Hamilton et al. profile →
APC mutations occur early during colorectal tumorigenesis

1992 1.5k citations Stanley R. Hamilton, Stephen N. Thibodeau et al. profile →
Mutation of a mutL Homolog in Hereditary Colon Cancer

1994 1.4k citations Stanley R. Hamilton, Gloria M. Petersen et al. profile →
Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications

1983 1.4k citations Stanley R. Hamilton et al. profile →
Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis

1993 1.4k citations Francis M. Giardiello, Stanley R. Hamilton et al. profile →
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer

1994 1.2k citations Stanley R. Hamilton, Gloria M. Petersen et al. profile →
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

2006 1.2k citations Stanley R. Hamilton et al. Journal of Clinical Oncology profile →
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

2010 1.1k citations Daniel J. Sargent, Silvia Marsoni et al. Journal of Clinical Oncology profile →
Allelotype of Colorectal Carcinomas

1989 1.1k citations Stanley R. Hamilton et al. profile →
Gene Expression Profiles in Normal and Cancer Cells

1997 1.0k citations Stanley R. Hamilton et al. profile →
Prognostic Factors in Colorectal Cancer

2000 993 citations Barbara A. Conley, Stanley R. Hamilton et al. profile →
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

1994 980 citations Jean‐Pierre J. Issa, Stanley R. Hamilton et al. profile →
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy

2009 915 citations Stanley R. Hamilton et al. Journal of Clinical Oncology profile →
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

1990 906 citations Stanley R. Hamilton et al. PubMed profile →
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

1997 814 citations Stanley R. Hamilton et al. profile →
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients

1996 749 citations Stanley R. Hamilton et al. profile →
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples

1991 731 citations Stanley R. Hamilton et al. profile →
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue

1985 725 citations Stanley R. Hamilton et al. profile →
The Molecular Basis of Turcot's Syndrome

1995 719 citations Stanley R. Hamilton, Steven M. Powell et al. profile →
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

1987 694 citations Stanley R. Hamilton et al. profile →
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

1994 690 citations Stanley R. Hamilton et al. PubMed profile →
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability

1995 678 citations Stanley R. Hamilton et al. profile →
Ischemic injury in the cat small intestine: Role of superoxide radicals

1982 642 citations Stanley R. Hamilton et al. Gastroenterology profile →
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms

1985 639 citations Stanley R. Hamilton et al. profile →
Increased Risk of Cancer in the Peutz–Jeghers Syndrome

1987 627 citations Francis M. Giardiello, Stanley R. Hamilton et al. profile →
Identification of a Gene Located at Chromosome 5q21 that Is Mutated in Colorectal Cancers

1991 606 citations Stanley R. Hamilton et al. profile →
Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors

1992 555 citations Stanley R. Hamilton et al. profile →
Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer

1994 552 citations Stanley R. Hamilton et al. profile →
Clonal Analysis of Human Colorectal Tumors

1987 506 citations Stanley R. Hamilton et al. profile →

Peers

Countries citing papers authored by Stanley R. Hamilton

Since Specialization

Citations

This map shows the geographic impact of Stanley R. Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley R. Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley R. Hamilton more than expected).

Fields of papers citing papers by Stanley R. Hamilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley R. Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley R. Hamilton. The network helps show where Stanley R. Hamilton may publish in the future.

Co-authorship network of co-authors of Stanley R. Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley R. Hamilton. A scholar is included among the top collaborators of Stanley R. Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley R. Hamilton. Stanley R. Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131) 2025 ·Clinical Cancer Research ·Mohamed A. Gouda,Filip Jankú,Ying Yuan,Leylah Drusbosky,Alice P. Chen,(unknown),Keyur P. Patel,Stanley R. Hamilton,Mark J. Routbort,James V. Tricoli,P. Mickey Williams,A. John Iafrate,Jeffrey Sklar,Brent Coffey,Richard F. Little,Carlos L. Arteaga,Peter J. O’Dwyer,Keith T. Flaherty,Lyndsay N. Harris,Funda Meric‐Bernstam	1
2	Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K 2025 ·Clinical Cancer Research ·Carolyn K. McCourt,Zihan Wei,Kevin Kalinsky,Robert J. Gray,Victoria Wang,Lisa M. McShane,Larry Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,Jeremy Force,(unknown),James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O’Dwyer,Alice P. Chen,Keith T. Flaherty	2
3	Dabrafenib and trametinib in patients with tumors with BRAF V600E/k mutations: Updated results from NCI-MATCH arm H. 2024 ·Journal of Clinical Oncology ·April K.S. Salama,Victoria Wang,Erin Macrae,Jong‐In Park,Helen X. Chen,Robert J. Gray,Lisa M. McShane,Larry Rubinstein,(unknown),Stanley R. Hamilton,Deborah K. Armstrong,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O’Dwyer,Alice P. Chen,Keith T. Flaherty	1
4	Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A 2024 ·JCO Precision Oncology ·Scott Gettinger,(unknown),Karen L. Reckamp,Jeffrey A. Moscow,Robert J. Gray,Victoria Wang,Lisa M. McShane,Larry Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,Xiao–Tang Kong,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O’Dwyer,(unknown),Keith T. Flaherty	2
5	Universal germline testing for cancer susceptibility and actionable noncancer disorders among 19,842 patients: Initial findings from the City of Hope INSPIRE study. 2024 ·Journal of Clinical Oncology ·Stacy W. Gray,Ilana Solomon,Heather Hampel,Michael Garcia,(unknown),(unknown),Gregory Idos,(unknown),(unknown),(unknown),Kevin McDonnell,Bita Nehoray,(unknown),(unknown),(unknown),Yi Xiao,(unknown),Joseph D. Bonner,Stanley R. Hamilton,Stephen B. Gruber	0
6	A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174). 2024 ·Journal of Clinical Oncology ·Jennifer R. Eads,Noah Graham,Michael K. Gibson,Lakshmi Rajdev,Anuradha Chakravarthy,Onkar V. Khullar,Steven H. Lin,Ignacio I. Wistuba,Rajiv Agarwal,(unknown),(unknown),Tareq Al Baghdadi,Ning Jin,Ryan Massa,Stanley R. Hamilton,Charles A. Staley,Terence Z. Wong,Peter J. O’Dwyer	10
7	Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial 2020 ·Clinical Cancer Research ·Jonathan M. Loree,(unknown),Dongsheng Tu,Derek J. Jonker,Daniel L. Edelstein,Hannah Quinn,Frank Holtrup,Timothy Price,John Zalcberg,Malcolm J. Moore,Christos S. Karapetis,Chris J. O’Callaghan,Paul Waring,Hagen F. Kennecke,Stanley R. Hamilton,Scott Kopetz	19
8	Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial 2017 ·Clinical Cancer Research ·Joseph D. Khoury,Wei‐Lien Wang,Víctor G. Prieto,L. Jeffrey Medeiros,Neda Kalhor,Meera Hameed,Russell R. Broaddus,Stanley R. Hamilton	44
9	Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing 2015 ·Molecular Cancer Therapeutics ·Jeannelyn S. Estrella,Michael T. Tetzlaff,Roland L. Bassett,Keyur P. Patel,Michelle D. Williams,Jonathan L. Curry,Asif Rashid,Stanley R. Hamilton,Russell R. Broaddus	33
10	Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia 2013 ·Cancer Prevention Research ·Angela N. Bartley,Nila U. Parikh,Chiu‐Hsieh Hsu,Denise J. Roe,Julie A. Buckmeier,Lynda Corley,(unknown),Gary E. Gallick,Peter Lance,Patricia A. Thompson,Stanley R. Hamilton	10
11	Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer 2011 ·Clinical Cancer Research ·Angela N. Bartley,Hui Yao,Bedia A. Barkoh,Cristina Ivan,Bal M. Mishra,Asif Rashid,George A. Călin,Rajyalakshmi Luthra,Stanley R. Hamilton	57
12	Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancerbreakdown → 2010 ·Journal of Clinical Oncology ·Daniel J. Sargent,Silvia Marsoni,Geneviève Monges,Stephen N. Thibodeau,Roberto Labianca,Stanley R. Hamilton,Amy J. French,Brian Kabat,Nathan R. Foster,Valter Torri,Christine Ribic,Axel Grothey,Malcolm Moore,Alberto Zaniboni,J. F. Seitz,Frank Sinicrope,Steven Gallinger	1114
13	Concordant DNA Methylation in Synchronous Colorectal Carcinomas 2009 ·Cancer Prevention Research ·Kazuo Konishi,Lanlan Shen,Jaroslav Jelı́nek,Yoshiyuki Watanabe,Saira Ahmed,Kazuhiro Kaneko,(unknown),(unknown),Michio Imawari,Stanley R. Hamilton,Jean‐Pierre J. Issa	37
14	The Previously Undescribed ZKSCAN3 (ZNF306) Is a Novel “Driver” of Colorectal Cancer Progression 2008 ·Cancer Research ·Lin Yang,Stanley R. Hamilton,Anil K. Sood,Toshio Kuwai,Lee M. Ellis,Ángela Sanguino,Gabriel Lopez‐Berestein,Douglas D. Boyd	68
15	Combination of 5-Fluorouracil and N1, N11-diethylnorspermine markedly activates spermidine/spermine N1-acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells 2005 ·Cancer Research ·Woonyoung Choi,Eugene W. Gerner,(unknown),Latha Ramdas,Jennifer S. Carew,(unknown),Peng Huang,Wei Zhang,Stanley R. Hamilton	0
16	Concordant CpG Island Methylation in Hyperplastic Polyposis 2002 ·American Journal Of Pathology ·Annie On-On Chan,Jean‐Pierre J. Issa,Jeffrey S. Morris,Stanley R. Hamilton,Asif Rashid	150
17	Identification of combination gene sets for glioma classification. 2002 ·PubMed ·Seungchan Kim,Edward R. Dougherty,Ilya Shmulevich,Kenneth R. Hess,Stanley R. Hamilton,Jeffrey M. Trent,Gregory N. Fuller,Wei Zhang	106
18	Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene 1998 ·Gut ·Jill D. Brensinger,Steven J. Laken,Michael C. Luce,Steven M. Powell,Gail H. Vance,D.J. Ahnen,(unknown),Stanley R. Hamilton,Francis M. Giardiello	91
19	Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. 1993 ·Gut ·Francis M. Giardiello,G.J.A. Offerhaus,(unknown),Anne J. Krush,Anne C. Tersmette,Susan V. Booker,(unknown),Stanley R. Hamilton	260
20	Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis 1993 ·Gastroenterology ·Francis M. Giardiello,Stanley R. Hamilton,Anne J. Krush,Johan A. Offerhaus,Susan V. Booker,Gloria M. Petersen	51

About Stanley R. Hamilton

Stanley R. Hamilton is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 400 papers that have together received 67.0k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (157 papers), Colorectal Cancer Treatments and Studies (103 papers) and Colorectal Cancer Screening and Detection (64 papers). The work is most often cited by research in Pathology and Forensic Medicine (31.8k citations), Oncology (34.1k citations) and Cancer Research (16.8k citations). Stanley R. Hamilton has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Bert Vogelstein, Eric R. Fearon, Scott E. Kern, Johannes L. Bos, Kenneth W. Kinzler, Francis M. Giardiello, Stephen N. Thibodeau, Alida M.M. Smits, Mark Leppert and Asif Rashid. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact